Can cyclosporine cause blurred vision?

Blurred Vision and Cyclosporine

Blurred vision is a recognized adverse effect of cyclosporine, though it occurs relatively infrequently and is typically mild and transient.

Evidence from FDA Drug Labeling

The FDA drug label explicitly lists blurred vision as an adverse effect of cyclosporine 1. In clinical trials of psoriasis patients, "abnormal vision" was reported in 1% to less than 3% of patients treated with cyclosporine 1. The drug label also describes more serious visual manifestations as part of cyclosporine-induced neurotoxicity, including visual disturbances (including blindness) as manifestations of Posterior Reversible Encephalopathy Syndrome (PRES) and encephalopathy 1.

Additionally, the FDA label notes that optic disc edema including papilloedema with possible visual impairment can occur secondary to benign intracranial hypertension, representing a rare but serious manifestation of cyclosporine-induced neurotoxicity 1.

Clinical Context and Mechanisms

Common Mild Visual Effects

• Blurred vision typically occurs as a transient, mild adverse effect in the early treatment period
• Most visual disturbances are self-limiting and do not require drug discontinuation
• The mechanism likely relates to cyclosporine's effects on tear film stability and ocular surface in some cases

Serious Neurotoxic Visual Manifestations

When blurred vision occurs as part of more serious neurotoxicity, it may be accompanied by:

• Impaired consciousness or confusion
• Convulsions
• Loss of motor function
• Headaches
• Changes in white matter on imaging 1

Predisposing factors for serious neurotoxicity include:

• Hypertension
• Hypomagnesemia
• Hypocholesterolemia
• High-dose corticosteroids
• High cyclosporine blood concentrations
• Graft-versus-host disease 1

Clinical Approach

If a patient reports blurred vision on cyclosporine:

1. Assess severity and associated symptoms - Determine if vision changes are isolated or accompanied by neurological symptoms (headache, confusion, seizures)

2. Check for predisposing factors - Measure blood pressure, serum magnesium, cyclosporine blood levels, and review concurrent medications

3. For mild, isolated blurred vision:

   • Reassure the patient this is a known, typically transient effect
   • Continue monitoring
   • Consider dose reduction if persistent and bothersome

4. For blurred vision with neurological symptoms:

   • Immediately reduce or discontinue cyclosporine 1
   • Obtain neuroimaging to evaluate for PRES
   • Consult neurology
   • Most cases are reversible with dose reduction or discontinuation 1

5. For progressive or severe visual impairment:

   • Obtain urgent ophthalmology consultation
   • Evaluate for optic disc edema/papilloedema
   • Consider discontinuation pending evaluation

Important Caveats

• The British Association of Dermatologists guidelines [2-2] extensively detail cyclosporine side effects but do not specifically list blurred vision among the commonly reported adverse effects, focusing instead on neurological effects like paraesthesia, tremor, and headaches
• This suggests blurred vision is less common in dermatological practice compared to transplant populations
• Recent research 3 actually shows that topical cyclosporine 0.05% improves visual quality in patients with dry eye syndrome by reducing corneal aberrations, highlighting the distinction between systemic and topical formulations

The key distinction: Mild transient blurred vision is manageable with monitoring, but vision changes accompanied by neurological symptoms require immediate intervention as they may herald serious neurotoxicity.